Studies have shown SLox-1 (soluble LOX-1), a measurable fragment of the LOX-1 molecule, to increase as a diagnostic marker in patients with coronary artery disease, diabetes, hypertension and metabolic syndrome [39]. Here, OLR1 is linked to metabolic syndrome.